Picture of Extendicare logo

EXE Extendicare Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Annual cashflow statement for Extendicare, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2021
December 31st
C2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line11.569.63475.296.7
Depreciation
Deferred Taxes
Non-Cash Items46.4-49.414.933.841.2
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-31.149.3-61.84.11-3.31
Change in Accounts Receivable
Change in Other Assets
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities63.498.923.3144164
Capital Expenditures-69.5-102-129-42-59.9
Purchase of Fixed Assets
Other Investing Cash Flow Items5.792574532.8-57.5
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-63.7156-84.5-9.11-117
Financing Cash Flow Items-1.86-0.0561.89-3.31-3.34
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-74.8-192-30.9-87.9180
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-75.362.7-92.146.7226